Controlled Substance Prescriptive Authority Information

Instructions for Controlled Substance Prescriptive Authority
Controlled Substance Prescriptive Authority Application
Statement of Preceptorial Experience/APRN Category
Statement of Controlled Substance Delegation

Bureau of Narcotics and Dangerous Drugs (BNDD)
Drug Enforcement Administration (DEA)

See statute, 335.019, RSMo
See rule, 20 CSR 2200-4.100 Advanced Practice Registered Nurse
See rule, 20 CSR 2200-4.200 Collaborative Practice


Effective August 28, 2018, APRNs, Physician Assistants and Assistant Physicians with an authorizing collaborative practice/supervisory agreement may now prescribe up to a 30-day supply of buprenorphine for patients receiving medication assisted treatment for a substance use disorder. Questions regarding buprenorphine prescribing should be addressed to BNDD at